Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
Mark E ShermanRobert A VierkantMatthew MastersDerek C RadiskyStacey J WinhamAmylou C DueckCeline M VachonAlpa V PatelLauren R TerasPublished in: Cancer prevention research (Philadelphia, Pa.) (2023)
We examined whether NSAID use, a modifiable exposure, is associated with breast cancer risk in postmenopausal women from the Cancer Prevention Study-II with self-reported benign breast disease, an often inflammatory condition associated with higher rates of breast cancer.